Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Impact of Non-Invasive Prenatal Genetic Screening and Genetic Counseling with Sheetal Parmar Natera TRANSCRIPT
Download PDFMar 20, 2022
Sheetal Parmar is the Head of Clinical Services at Natera, a clinical genetic testing company. She draws on her experience as a prenatal genetic counselor to address the need for more accurate and available non-invasive prenatal genetic testing. This kind of information can guide women and their care teams and can also help emotionally prepare families. Sheetal looks forward to seeing more genetic markers being used to identify other types of pregnancy health.
Sheetal explains, "People want to know, what are all the different options of testing? You can want to know as little information as possible or no information, all the way to "I want all the testing that could possibly be available for me or for the pregnancy." I think those are the type of questions that come up. Or "I have this in my family history. Will this test help me with that?" We want to make sure the right test is ordered based on the information that's needed for that patient based on their values and their beliefs, and what they want to know."
"There has been a significant drop in the number of invasive tests that are done. I recall when I was first starting in practice, I worked with an OB geneticist, and we would do like seven of these a day. Now it might be seven a week, maybe less than that in his practice. It's pretty rare because of the screening tests that are available now, non-invasive prenatal testing is such an accurate screening test compared to what was previously available that there are much fewer false positives and false negatives. Much fewer women are pulled out as a high risk that would then need to be offered to be tested."
#Natera #NIPT #NonInvasivePrenatalTesting #GeneticCounselor #GeneticTesting #GeneticScreening #PrenatalCare
